Image-guided radiation therapy

Siteman Cancer Center Begins Treatment with Latest Mevion Proton Therapy System

Retrieved on: 
Thursday, November 16, 2023

Mevion Medical Systems announced today that the world’s first single-room proton therapy system has completed the upgrade to the latest MEVION S250i Proton Therapy System® with FLASH* capabilities, and has begun treating patients in November at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO.

Key Points: 
  • Mevion Medical Systems announced today that the world’s first single-room proton therapy system has completed the upgrade to the latest MEVION S250i Proton Therapy System® with FLASH* capabilities, and has begun treating patients in November at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO.
  • View the full release here: https://www.businesswire.com/news/home/20231116635095/en/
    The MEVION S250i Proton Therapy System (Photo: Business Wire)
    Siteman Cancer Center is an NCI-designated Comprehensive Cancer Center that draws patients from Missouri, Southern Illinois and beyond.
  • “Our team also looks forward to advancing FLASH dosimetry research.”
    This latest system incorporates Mevion's cutting-edge HYPERSCAN® Pencil Beam Scanning for Intensity Modulated Proton Therapy (IMPT) with a proton MLC, along with an advanced 3D imaging system for high-precision Image-Guided Radiation Therapy (IGRT) and adaptive therapy.
  • These latest capabilities are the result of a collaborative effort between Mevion and Siteman Cancer Center, initiated in 2019.

Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan

Retrieved on: 
Wednesday, November 9, 2022

Hospitals participating in the study include Qilu Hospital of Shandong University, Fudan (Shanghai) University Hospital and Peking University Peoples Hospital.

Key Points: 
  • Hospitals participating in the study include Qilu Hospital of Shandong University, Fudan (Shanghai) University Hospital and Peking University Peoples Hospital.
  • We are very pleased to hear that the study is progressing well, both in terms of patient recruitment and the performance of LuViva, said Gene Cartwright, CEO of Guided Therapeutics.
  • The Companys first product is the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care.
  • The Guided Therapeutics LuViva Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc.

American Shared Hospital Services Announces Second Quarter 2021 Earnings Conference Call

Retrieved on: 
Thursday, August 5, 2021

San Francisco, CA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a quarterly conference call to discuss its second quarter 2021 financial results on Thursday, August 12th, 2021 at 3:00pm EST / 12:00pm PST. The second quarter 2021 financial results press release will be issued premarket the morning of Thursday, August 12th, 2021.

Key Points: 
  • San Francisco, CA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a quarterly conference call to discuss its second quarter 2021 financial results on Thursday, August 12th, 2021 at 3:00pm EST / 12:00pm PST.
  • The second quarter 2021 financial results press release will be issued premarket the morning of Thursday, August 12th, 2021.
  • To participate, please call 1 (877) 317-6789 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call.
  • About American Shared Hospital Services (NYSE American: AMS)
    American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.

Accuray Customers Achieve Top Scores in AAPM MArkerless Lung Target Tracking CHallenge (MATCH) Using Synchrony® Technology on the Radixact® and CyberKnife® Systems

Retrieved on: 
Thursday, April 29, 2021

b'SUNNYVALE, Calif., April 29, 2021 /PRNewswire/ --Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (MATCH) experimental branch using the Accuray Synchrony Lung Tracking with Respiratory Modeling on the Radixact next-generation TomoTherapy platform, and CyberKnife System , respectively.

Key Points: 
  • b'SUNNYVALE, Calif., April 29, 2021 /PRNewswire/ --Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (MATCH) experimental branch using the Accuray Synchrony Lung Tracking with Respiratory Modeling on the Radixact next-generation TomoTherapy platform, and CyberKnife System , respectively.
  • "As part of the process, more than 200 image-guided radiation therapy (IMRT) QA plans were delivered, with the majority being markerless (fiducial-free) lung tumor plans.
  • "Synchrony on the Radixact and CyberKnife Systems enables highly accurate and efficient delivery of (ultra) hypofractionated radiation therapy, increasingly being used to treat a range of lung tumors.
  • "\nAccuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible.

3D CT Imaging Expert Joins Izotropic Advisory

Retrieved on: 
Thursday, January 7, 2021

His research is focused on new medical imaging technologies and algorithms, including CT and cone-beam CT (CBCT), image reconstruction and registration, and the physics of image quality.

Key Points: 
  • His research is focused on new medical imaging technologies and algorithms, including CT and cone-beam CT (CBCT), image reconstruction and registration, and the physics of image quality.
  • Dr. Siewerdsen's contributions include the development of new 3D imaging systems for image-guided radiation therapy, image-guided surgery, and point-of-care diagnostic imaging in orthopaedics and neuro-critical care.
  • Underlying such systems are advanced algorithms for high-quality 3D image reconstruction and registration as well as mathematical models of 3D image quality to optimize the design of new imaging systems for particular imaging tasks.
  • Dr. Siewerdsen's appointment to the Scientific Advisory Board expands the Company's expertise in developing the Breast CT imaging platform for new and complementary products.

Novel Coronavirus' Impact on Radiation Therapy Markets, 2020-2024 - Slowdown in Emerging Markets, Change in Organic Traffic, Impact on Radiation Therapy, Risk Factors for Severe Adverse Events

Retrieved on: 
Wednesday, May 13, 2020

The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.

Key Points: 
  • The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
  • Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing ageing population and expanding urbanization are expected to drive the global radiation therapy market.
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.

Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 12, 2020

The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.

Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Retrieved on: 
Monday, May 4, 2020

The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.

Key Points: 
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.
  • Whereas, on the basis of devices, the global external beam radiation therapy market can be segmented into three categories, named as, LINAC (Linear Accelerators), proton beam therapy devices and compact advanced therapy devices.
  • The report provides a comprehensive analysis of the global radiation therapy market segmented on the basis of type.

ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care

Retrieved on: 
Wednesday, April 1, 2020

The collaboration is designed to drive personalized care and treatment to patients by educating oncology practices on both companies' precision oncology solutions.

Key Points: 
  • The collaboration is designed to drive personalized care and treatment to patients by educating oncology practices on both companies' precision oncology solutions.
  • VCurePrecision provides a real-time decision-support system that combines clinical knowledge with patient data to assist oncologists in generating personalized treatment plans and managing a patient's care throughout his or her cancer therapy.
  • "Both VieCure and ViewRay are leaders within their field bringing clinicians a state-of-the-art AI-powered patient data system and the world's first MRI-guided radiation therapy system.
  • The platform also incorporates AI clinical rules to personalize standard of care to the specific characteristics of an individual's cancer.

Global Radiation Therapy Market Analysis & Trends During the Forecast Period, 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, December 30, 2019

The "Radiation Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026" report has been added to ResearchAndMarkets.com's offering

Key Points: 
  • The "Radiation Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026" report has been added to ResearchAndMarkets.com's offering
    This report analyzes the current and future scenario of the global radiation therapy market.
  • The global radiation therapy market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.
  • Based on type, the global radiation therapy market has been segmented into external-beam radiation therapy and internal radiation therapy.
  • The external-beam radiation therapy segment has been divided into conformal radiation therapy, proton beam therapy, image guided radiation therapy, and others.